Studies on the Stability of Lyophilized BCG Vaccine  *† by Miller, Russell & Goodner, Kenneth
STUDIES ON THE STABILITY OF LYOPHILIZED
BCG VACCINE*t
RUSSELL MILLER, JR.** AND KENNETH GOODNER
The application of lyophilization to the preservation of BCG, in an effort
to combat the rapid loss in allergenic potency of the liquid vaccine, has
presented important technical difficulties. Although the effectiveness of
lyophilized BCG in producing tuberculin conversion appears to be as great
as that of the fresh vaccine,"118,2 clinical experience has shown that its use
engenders quantitatively lessened tuberculin reactions"'5 that frequently are
temporally delayed."7'18'2' More important, however, is the fact that the
protective value of lyophilized vaccines against challenge infection with
virulent tubercle bacilli is less than that produced by fresh, liquid vaccines."'
Inasmuch as the allergenic potency of the vaccine has been shown to be a
function of the viability of the suspension5'9 the failure of dried vaccines has
been attributed to the large decrement in viable cells that occurs during the
period of lyophilization itself,"5 and the smaller decrease that occurs in the
storage period which follows.
Initial attempts at prolonging the effective life of BCG vaccine were made
in Russia in 1937.1' From the start, workers have experienced difficulty, and
the tendency has been to use accessory substances along with the vaccine
suspension to enhance its stability. Excipients such as glucose,""' starch,"
lactose,'
" 16 gelatin,' denatured gelatin,'5 serum,6'2 sucrose, gum arabic,"1
peptone solution,9 sodium ammonium pectate, and glutamic, malic, and
succinic acids' have been tried. It has been suggested recently that Tween-
albumin medium, as used for diffuse, submerged growth of Mycobacterium
tuberculosis, be used as the vehicle for lyophilization.'5 Rosenthal'8 has
reported excellent results using a mixture of lactose, asparagin, buffered
salts, and glycerine as a suspending menstruum. Reported s-urvival rates
vary from 100 per cent2'" to about 14 per cent,'0 immediately following
lyophilization. Birkhaug' reports a survival rate of 2.83 to 3.26 per cent
three to twelve months after freeze-drying.
Preliminary experiments carried out in this laboratory having supported
the reports of low survival rates following lyophilization and, further, hav-
ing indicated that BCG could not be successfully stabilized in the absence of
drying excipients a survey has been made of sixty-two adjuvants, embracing
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the general classes of carbohydrates, organic acids, amino acids and their
salts, proteins and digests, gums, and miscellaneous reagents, in order to
determine if freeze-drying could be accomplished in a manner that would
reduce cellular mortality to a minimum. In addition, because of the sugges-
tion of intrinsic difference in vaccine preparations,11 nine strains of BCG and
one strain of the vole bacillus have been studied to determine if any particu-
lar strain could withstand the stresses imposed by lyophilization better than
others.
MATERIALS AND METHODS
Cultures.*
The nine strains of BCG used in this investigation were:
1. Strain 31: old vaccine strain, Phipps Institute, Philadelphia, Pennsylvania. (Dr.
J. D. Aronson)
2. Strain 186: old Norwegian strain. (Dr. J. B0e)
3. Strain 425: Swedish strain. (Dr. A. Wassen)
4. Strain 805: strain from the New York State Laboratory, Albany, New York.
(Dr. K. Birkhaug)
5. Strain 826: strain from the Trudeau Foundation, Saranac Lake, New York.
(Dr. A. J. Vorwald)
6. Strain 858: strain from the Tice Laboratories, Chicago, Illinois. (Dr. S. R.
Rosenthal)
7. Strain 862: strain from the Tice Laboratories, Chicago, Illinois. (Dr. S. R.
Rosenthal)
8. Strain 873: strain from the Pasteur Institute, Paris, France.
9. Strain B59: strain from the New York State Laboratory, Albany, New York.
(Dr. K. Birkhaug)
The murine strain of tubercle bacillus was:
1. Strain 17OV: strain from the Dunn School of Pathology, University of Oxford,
Oxford, England. (Dr. A. Q. Wells)
As each culture was received, a transfer was made to a slant of Lowenstein-Jensen's
medium. Cultures were sealed with paraffin and incubated at 380 C. These constituted
the stock cultures.
For use the stocks were transferred to glycerinated water potato medium. Cultures
were incubated at 38° C., at such an angle of inclination that the fluid surface formed
a plane with the flattened face of the potato slab.
For the preparation of the vaccine, small portions of the veil of growth on the liquid
phase of the culture were transferred to flasks of Sauton's medium. It was found
convenient to use Erlenmeyer flasks of 125 ml. capacity, containing approximately
50 ml. of medium. After five to six days' incubation at 38° C. the culture covered the
surface of the medium as a thin veil. By the ninth or tenth day the surface growth was
markedly thickened and puckered. It was cream to yellow in color, depending upon the
strain of BCG that was being grown. Growth was harvested on the tenth day, and the
vaccine was prepared for lyophilization.
* All of the cultures used in this investigation were supplied through the courtesy of
Dr. Joseph D. Aronson of the Henry Phipps Institute, University of Pennsylvania,
Philadelphia, Pennsylvania.
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Preparation of BCG vaccine. The procedure to be described represents, in general,
the standard method of preparing BCG vaccine suspensions as carried out in this
investigation. Modifications of the established technique, as called for in individual
experiments, are indicated in the respective protocols.
Bacilli from ten-day-old Sauton cultures were separated by draining off the culture
fluid through a sterile Seitz filter in which the asbestos pad had been replaced by a
double thickness of WhatmanX4 filter paper, cut to appropriate size. The filter was
carefully disassembled and the bacillary mass transferred with a minimum of handling
to the center of a small pile of sterile filter papers. A heavy weight was placed upon
the pile for approximately ten minutes in order to remove excess moisture.
Portions of the bacillary mat were transferred by means of a spatula to a heavy
pyrex grinding flask of 1000 ml. capacity, containing one-half kilogram of marble balls.
The flask was rotated at 60 rpm. for five minutes. At this time, gross inspection of the
bacillary mass showed it to be rather finely divided. Microscopic examination revealed,
however, that the suspension was coarsely clumped. Ten ml. of a 50 per cent solution
of glucose were added to the flask and rotation was continued for another five minutes.
The suspension appeared homogeneous and darkfield microscopy revealed only occa-
sional clusters of bacilli. Sufficient 50 per cent glucose was added to bring the bacterial
concentration to 0.2 mg. dry weight of bacilli per ml. of grinding menstruum, as deter-
mined spectrophotometrically (vide infra). After an additional five-minute rotation,
darkfield preparations were composed for the most part of freely dispersed bacilli.
At the end of the grinding period, portions of the vaccine suspension were transferred
into sterile centrifuge tubes and the exact volume was noted. The tubes were centrifuged
in the cold (10 C.) for ten minutes at 3000 rpm. The supernatant fluid was decanted
and the packed cells were washed with M/15 phosphate buffer at pH 7.0. Washings
were repeated five times, after which the cells were resuspended in phosphate buffer to
one-tenth of the original volume. The bacterial concentration was thus brought to
2 mg. dry weight of bacilli per ml. of suspension fluid.
Aliquots of the vaccine were mixed with equal volumes of adjuvant solution, bringing
the final bacterial concentration to 1 mg. dry weight of bacilli per ml. of suspension
fluid. One ml. amounts of the vaccine were delivered from a glass syringe fitted with
a 3-inch 19-gauge needle directly into the bottom of five ml. pyrex ampoules (body
60 mm. long, o.d. 15 mm.; stem 60 mm. long, o.d. 8 mm.). In this manner, loss of
vaccine due to adherence of drops of the suspension in the stem of the ampoule was
avoided. Routine sterility tests were carried out in fluid thioglycollate medium at the
end of the period of grinding and after the final washing of the vaccine suspension.
Standardization of vaccinesuspensions. For each point to be established on a dry
weight curve indicating opacity as a function of the dry weight, it was necessary to
disperse a semi-dry weight of bacteria approximately four times as great.8 The opacity
of the suspension was carefully measured using a ColemanJunior spectrophotometer,
at a wave length of 520 millimicrons. Five ml. of vaccine suspension were pipetted into
an acid-washed, tared centrifuge tube. The bacilli were packed by centrifugation in the
cold at high speed. When sedimentation appeared complete, the supernatant was de-
canted and an additional five ml. of the vaccine suspension were added to the tube. This
process was repeated ten times so that eventually the bacterial pellet at the bottom of
the tube represented the concentrate from 50 ml. of the vaccine suspension. The centri-
fuge tube was placed in a desiccator over "Drierite" (anhydrous CaSO4) and dried to
constant weight. All weighings were made to the nearest tenth of a milligram, and the
dry weight of the cells, determined by difference, was computed to a ten-ml. volume.
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This value was plotted against the percentage light transmission reading. The best
straight line was drawn through the experimental points, and the percentage light
transmission readings corresponding to the desired milligram weights were determined
by inspection. The experimental results are presented graphically in Figure 1.
Technique of lyophilization. Prior to lyophilization, pre-freezing was accomplished by
means of external cooling with the aid of a low temperature liquid bath of dry ice and
acetone. Ampoules were shell frozen in order to present a maximal surface for
evaporation together with a minimal depth of frozen material.
Two lyophile machines were utilized in this investigation. The larger of the two
machines conveniently accommodated 62 ampoules, the smaller, 46. An oil-sealed, high
vacuum pump of the rotary type (Cenco Megavac) was used in drawing the vacuum,
the extent of which was
1oo- measured with a standard
___-_ \.___
McLeod gauge. Water
90z _\_ vapor was removed by
°o- \ condensation at low tem-
70 _____ Fperature. The heat neces-
z \ sary for desiccation was
*0 - . supplied by convection
Z 50 - _____ _____ _____ from the surrounding air. Go-.x
40_-___\ In practice, a vacuum
of 0.05 to 0.1 mm. Hg on
0 s- "blank suction" was at-
" o 20-_ .tained before any of the
ampoules were attached to
10- the machine. When this
level was reached, the
i 1.0 1.5 2.0 2.5 a.o shell-frozen ampoules
began at once. All dry-
MG. DRY WEIGHT OF BACTERIA PER IOML. ings were carried out at
FIG. 1. Percentage of light transmission as a function of a level of 0.015 mm. Hg.
dry weight of bacteria. Leaks in the system were
indicated by failure to ob-
tain a sufficiently high vacuum within a reasonable length of time, or by a fall in the
vacuum as indicated by the McLeod gauge. Defective ampoules were located with a
high frequency spark coil tester of the Tesla type.
The length of time necessary for all condensation on the outer walls of the ampoules
to disappear was noted, and then one-half that number of hours additional was allowed
to reduce the moisture content within the ampoules to the proper final level of approxi-
mately 1 per cent. At the end of the period of desiccation the vacuum pump was turned
off and the ampoules were charged with dry nitrogen. They were then sealed with an
oxygen flame using a standard Hoke torch fitted with a cross fire attachment.
Method of titration. Independent, duplicate titrations were carried out in Youman's
medium to determine the highest dilution to which growth of freshly prepared and
lyophilized vaccine suspensions would occur. Serial ten-fold dilutions of freshly pre-
pared or reconstituted lyophilized vaccines were made using separate 1 ml. delivery
pipettes and after pipetting the mixture up and down ten times. Dilutions were carried
out to a level of 10', and after a specified period of time, the greatest dilution at
which growth occurred was noted. Only in exceptional instances was there a disparity
in the results of duplicate titrations. All culture tubes were provided with aluminum
caps in order to obviate any possibility of inhibitory substances becoming incorporated
in the medium through the use of cotton plugs.8
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EXPERIMENTS
The effect of hydrogen ion concentration upon the preservation of Iyo-
philized BCG. The standard technique was modified in that an eleven-day-
old Sauton culture of BCG, strain 858, was ground in M/15 phosphate
buffer at pH 7.0 for 25 minutes. The bacterial concentration was brought to
0.2 mg. dry weight of bacilli per ml. of grinding menstruum. Twenty ml.
aliquots were pipetted into sterile test tubes which were centrifuged in the
TABLE 1
THE EFFECT OF HYDROGEN ION CONCENTRATION UPON THE PRESERVATION OF
LYOPHILIZED BCG (THE FIGURES REPRESENT THE NEGATIVE LoG10
TITER OF GROWTH)
After 8 After 8
Immediately after weeks' storage weeks' storage
Series lyophilization at 40 C. at 380 C.
no. pH 3weeks 5 weeks 3weeks 5weeks 3weeks 5 weeks
1 4.48 2 3 1 2 Nogrowth 1
2 5.08 2 3 2 2 No growth 1
3 5.59 2 3 2 3 1 1
4 6.11 3 4 2 3 1 2
5 6.50 3 5 3 5 2 2
6 7.05 3 7 2 6 3 5
7 7.42 3 6 3 5 1 1
8 8.12 2 3 2 3 1 1
9 8.56 2 3 2 2 No growth 1
Control* 7.05 5 9
*Unlyophilized.
cold at high speed until sedimentation appeared complete. The supernatant
fluid was decanted, and the bacterial pellet was twice resuspended and
washed in phosphate buffer solutions at a pH at which the drying was to be
carried out. After the final washing, the bacilli were resuspended in one-
fifth volume of appropriate buffer solutions. Of the four ml., three were
utilized for lyophilization, as previously described, and one for determina-
tion of the actual pH of the bacillary buffer mixture, using a Beckman
Model G laboratory pH meter. Immediately after lyophilization, one series
of ampoules was opened and the dried vaccine reconstituted in 0.9 per cent
saline. Titrations to determine the highest dilution at which growth would
still occur were carried out in Youman's medium. Of the remaining two
series of ampoules, one was stored for a period of eight weeks in the
refrigerator at 40 C., and the other in a laboratory incubator at 380 C. for
a similar period of time. The highest dilution at which growth occurred was
determined at three and five weeks. The results are summarized in Table 1.
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Reference to the table will indicate that there was decreased growth on
either side of neutrality. Though the decrement was unimportant when the
vaccine was used immediately after lyophilization, or even after eight weeks
storage at 40 C., the loss in viable elements became disproportionately large
when the ampoules were exposed to thermal stress.
The effect of the age of the culture upon the ability of lyophilized BCG
to withstand storage after lyophilization. Ten flasks of Sauton's medium
were inoculated on the same day with portions of the veil from a glycerinated
water potato culture of BCG, strain 873. On the 8th, 10th, 15th, 20th, and
25th day of culture the contents of two
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FIG. 2. The effect of the age of the culture
upon the ability of lyophilized BCG to with-
stand storage at refrigerator and incubator
temperatures.
flasks were pooled, harvested, and
lyophilized according to standard
technique. Sodium glutamate was
used as the drying adjuvant, since
other experiments carried out in
this investigation had indicated
that it offered a high degree of
protection against thermal stress.
One series of ampoules was
opened immediately after lyophil-
ization and reconstituted in 0.9
per cent saline. Titrations to de-
termine the highest dilution at
which growth still occurred were
carried out after three weeks'
incubation at 37° C. Similar pro-
cedures were applied to ampoules
stored for eight weeks at 40 C.,
and for those stored at 380 C.
The results, which are represented graphically in Figure 2, indicate that
with increasing age of the culture there was a decreasing ability to with-
stand storage after lyophilization. The loss in viability was most marked
when the ampoules were stored at 370 C., although after 25 days of,culture
no viable elements could be recovered from lyophilized material that had
been stored at either refrigerator or incubator temperature. The losses do
not appear to be due to decreased viability of the culture since there was a
variation of only one tube in the highest dilution to which growth occurred
from the youngest to the oldest culture, with respect to unlyophilized mate-
rial. This loss does not appear to be related to a decreased vitality of the
strain since the initial loss on lyophilization never exceeded an expected one
or two dilution tubes.
The influence of room temperature on the viability of the vaccine
suspension. Inasmuch as the preparation of the vaccine suspension required
a considerable length of time, experiments were conducted to determine if
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there was an important loss of viable elements resulting from prolonged
standing at room temperature.
BCG strain 425 was used for this study. Vaccine suspensions were
prepared in quadruplicate by the usual technique, but were not lyophilized.
Three suspensions were permitted to stand at room temperature. No
attempt was made to reduce the ordinary illumination of the room, but the
vaccines were shielded from direct sunlight. The first suspension was not
altered in any manner. To the second was added 0.1 per cent by volume of
a 10 per cent solution of Armour's bovine albumin, Fraction V, and to the
third 1 per cent by volume of a 10 per cent sucrose solution. The fourth
vaccine was unaltered, but was stored at refrigerator temperature. Titra-
TABLE 2
THE EFFECT OF PROLONGED STANDING AT RooM AND REFRIGERATOR TEMPERATURES
UPON THE VIABILITY OF VACCINE SUSPENSIONS (THE FIGURES REPRESENT THE
NEGATIVE LOG1o TITER OF GROWTH)
Time of titration
Nature of vaccine Immediate 4 hours 8 hours 24 hours
Unaltered, room temperature 8 8 7 5
Bovine albumin added; room
temperature 8 8 8 7
Sucrose added; room temperature 8 8 8 6
Unaltered; refrigerated 8 8 8 8
tions were carried out immediately after the preparation of the vaccines,
and at four, eight, and twenty-four hours. The results are summarized in
Table 2.
It may be seen that for a period of four hours there was no loss in any
of the four samples. At the end of eight hours the first sample showed a ten-
fold decrease in titer and this increased to a thousand-fold loss in viable ele-
ments at the end of 24 hours. In the presence of bovine albumin and sucrose
the loss at 24 hours was ten-fold and one hundred-fold respectively. Only
the refrigerated vaccine was able to maintain its titer.
The degree of dispersion was determined for each preparation at the
time titrations were made. Differences of a magnitude which could have
been construed to have been significant in the production of the variable
titers were not obtained in any instance.
The effect of bacterial dispersion upon the efficiency of lyophilization. To
determine if efficiency of drying was a function of the degree of dispersion
of the vaccine suspension, equivalent weights of BCG, strain 873, were
ground in the presence of phosphate buffer, at varying rates of rotation for
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equal periods of time. At the end of the grinding periods, smears were pre-
pared and the percentage of freely dispersed bacilli was noted. Lyophiliza-
tion was carried out in the presence of sodium glutamate, and, in the usual
manner, decimal dilutions were made in Youman's medium to determine
the highest dilution at which the
vaccine suspension would still
UNLYOPHILIZCD CONTROL
IMMEDIATELV AFTER AlfftiP
LYOPLIZATIO grow. Ampoules were stored in
AFEREIGT WEEKS f A"TORgAEAT WEES the refrigerator and at incubator
EJSTORAGE. AT 36'C X10) STORAOg.^T }@*e temperature for a period of eight
weeks. The results are presented
~IO ,0ia g |graphically in Figure 3. It may
be noted that the poorer the dis-
_ oS persion, the poorer the ability of
3otI E k > | of the vaccine suspension to with-
stand lyophilization. A dispropor-
° ,0 § § g g -_ tionate decrease in the thermal
3 - S E g L stability of poorly dispersed, glu-
64 67 32 lo tamate dried suspensions is evi-
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FIG. 3. The effect of bacterial dispersion The importance of the drying
upon the efficiency of lyophilization. adjuvant in combatting the loss of
viable elements during lyophilization. In this experiment, all available strains
of BCG, and a strain of the vole bacillus were studied with respect to their
TABLE 3
NEGATiVE LoG1o IN TITER IMMEDIATELY AFTER LYoPHILIZATION, IN THE PRESENCE
OF A SELECTED SERIES OF ADJUVANTS
Number of strain
Adjuvant 858 425 805 31 873 B59 826 862 186 170V
Galactose d 2 2 1 3 2 3 2 4 1 3
Glucose 1 1 1 2 2 1 1 2 1 2
Sucrose 2 1 3 2 2 3 3 2 3 2
Lactose 1 1 1 2 1 2 2 2 1 2
Sodium glutamate 1 2 3 2 1 1 1 2 1 2
Sodium aspartate 2 1 2 3 2 2 4 1 2 3
Gelatin 5 5 4 6 5 7 4 3 5 6
ability to withstand the stress of lyophilization when dried in the presence
of various adjuvants. The agents used for drying embraced the general
classes of carbohydrates, organic acids, amino acids and their salts, proteins
and digests, and gums. A group of adjuvants not easily classified were
included under the general heading, miscellaneous. Unless otherwise noted,
all strongly acidic or basic compounds were neutralized prior to use.
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Each of the adjuvants was used for the preparation of a vaccine suspen-
sion of the ten separate cultures, and the negative logio decrement in titer,
i.e., the difference in the titer of growth between the unlyophilized and lyo-
philized vaccine suspensions, was determined for each of the ten strains.
Table 3 gives the negative log1o decrement in titer for the six adjuvants
found to be most useful, and for one adjuvant considered to be poor, with
reference to each particular strain. It is evident that there was no marked
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CONCENTRATION OF GLUCOSE (PERCENT)
FIG. 4. The effect of varying concentrations of glucose upon the ability of vaccine
suspensions to withstand lyophilization.
strain difference in the ability to withstand lyophilization, since the variation
in the degree of recovery, with any particular adjuvant, was not marked.
An adjuvant which was good afforded protection to all strains, and
conversely, a poor adjuvant was poor with respect to all strains.
An index of efficiency was determined for each adjuvant by adding
together the log1o decrements in titer for the ten strains of mycobacteria.
For the purpose of this investigation, any adjuvant whose index of efficiency
was 25 or lower was considered worthy of further study.
The adjuvants used, their final concentrations within the ampoules, and
their indexes of efficiency are listed in Table 4. It may be noted that of the
six adjuvants that appeared to offer a significant degree of protection to the
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TABLE 4
THE ADJUVANTS, THEIR CONCENTRATIONS AND INDEXES OF EFFICIENCY
Final concentration
Adjuvant in ampoule (%) Index of efficiency
Carbohydrates
Mannitol d 5 38
Fructose 5 28
Mannose d 5 31
Galactose d 5 23
Xylose 1 5 35
Inulin 5 33
Dextrin 5 30
Raffinose 5 41
Dulcitol 1 44
Salicin 1 29
Inositol 1 37
Sorbitol d 1 47
Adonitol 1 48
Starch, soluble 0.5 50
Xylose d 1 38
Maltose 5 34
Glucose 5 14
Sucrose 5 22
Lactose 5 15
Organic acids
Succinic acid 0.5 45
p-amino benzoic acid 0.15 40
Adipic acid 0.5 47
Malonic acid 0.5 43
Glutaric acid 0.5 34
Ascorbic acid 0.5 50
Sodium citrate 5 42
Azelaic acid 0.1 50
Valeric acid 0.5 43
Pimelic acid 0.5 48
Gluconic acid 0.5 37
Nicotinic acid 0.5 42
Amino acids, and their salts
Tyrosine 0.5 49
Cystine 0.5 47
Histidine 0.5 47
Sodium glutamate 1 16
Alanine 0.5 33
Glutamic acid* 0.5 50
Arginine 0.5 50
* Unneutralized.YALE JOURNAL OF BIOLOGY AND MEDICINE
Final concentration
Adjuvant in ampoule (%) Index of efficiency
Asparagin 0.5 31
Lysine 0.5 43
Aspartic acid* 0.5 47
Sodium aspartate 1 22
Glycine 0.5 42
Proteins and digests
Trypticase 1 56
Amigen 5 52
Neopeptone 0.5 44
Mucin 0.5 53
Gelatin 0. 50
Gums
Arabic 0.25 30
Tragacanth 0.25 34
Ghatti 0.25 36
Miscellaneous
Brain heart infusion 1.85 46
Creatinine 0.5 51
Liver extract 1 58
Guanidine sulphate 0.5 51
Water, distilled ... 50
Saline 0.85 42
Sulfathiazole 0.5 52
Kaolin 1 41
Horse serum 5 30
Charcoal 5 53
Urea 0.5 50
* Unneutralized.
bacilli, four were carbohydrates (galactose, glucose, sucrose, lactose), and
two were salts of organic acids (sodium glutamate, sodium aspartate).
The optimal concentration of adjuvant solutions to be used in lyophiliza-
tion. This experiment was carried out using BCG strain 862. Since it had
been noticed that high concentrations of carbohydrates were exceedingly
difficult to dry with any degree of success due to "bubbling" and loss of
vaccine through the stem of the ampoule, and in view of the report that high
salt concentrations were detrimental to survival,7 experiments were under-
taken to determine the optimal amounts of selected adjuvants to be used in
lyophilization. As a typical carbohydrate, glucose was chosen; as a typical
salt, sodium glutamate was selected. Vaccine suspensions were prepared and
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lyophilized in 0.5, 1, 2, 5, 10, 20, 30, 40, and 50 per cent glucose. The final
concentration within the ampoules was one-half of these values. Similarly,
suspensions were prepared and lyophilized in the presence of 0.1, 0.2, 0.25,
0.5, 1, 2, 5, and 10 per cent sodium glutamate. Again, the final concentration
within the ampoules was one-half of these values. One series of ampoules,
consisting of both glutamate and glucose dried vaccines was opened immedi-
ately after lyophilization, another glucose dried series after eight weeks'
storage at 40 C., and a third glutamate dried series after a similar period of
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FIG. 5. The effect of varying concentrations of sodium glutamate upon the ability of
vaccine suspensions to withstand lyophilization.
storage at 380 C. Titrations were carried out in Youman's medium as
previously described. The results are presented graphically in Figures 4
and 5.
It may be seen that with carbohydrate dried material there was little
difference in the efficiency of drying, regardless of the concentration of the
carbohydrate used, except for the extremely low final concentrations of 0.25
and 0.5 per cent. However, in the case of glutamate dried material, there
was a definite optimal range of salt concentrations, and in agreement with
previously published data, high salt concentrations were found to be
detrimental to survival.
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The ability of lyophilized BCG to withstand prolonged storage at refriger-
ator and incubator temperatures. This investigation was carried out with
BCG strain 858. Vaccine suspensions were lyophilized in the presence of all
adjuvants according to standard technique. Titrations were carried out
upon the unlyophilized vaccine and upon the lyophilized product immedi-
ately after freeze-drying. Corresponding ampoules were stored in the
refrigerator at 40 C., and in a laboratory incubator at 380 C. The greatest
dilution at which growth still occurred was again determined after three and
ten months. The results for seven of the adjuvants tested are given in
Table 5.
TABLE 5
THE ABILITY OF LYOPHILIZED BCG TO WITHSTAND PROLONGED STORAGE AT
REFRIGERATOR AND INCUBATOR TEMPERATURES (THE FIGURES
REPRESENT THE NEGATIVE LOGio TITER OF GROWTH)
Immedi-
ately Length of storage
Unlyophil- after
ized lyophili- 3 months 10 months
Adjuvant control zation 40 C. 38° C. 40 C. 380 C.
Galactose d 6 4 3 3 3 1
Glucose 7 6 6 1 5 Nogrowth
Sucrose 7 5 5 2 4 Nogrowth
Lactose 7 5 4 2 4 1
Sodium glutamate 6 5 4 4 4 4
Sodium aspartate 8 5 5 4 5 5
Gelatin 6 1 1 Nogrowth Nogrowth Notdone
It may be noted that the carbohydrates offered the greatest protection to
the bacilli during a period of prolonged storage at refrigerator temperature.
A few amino acids and organic acids seemed to afford protection at refriger-
ator temperatures, but the proteins, gums, and miscellaneous reagents were
poor in this respect.
Adjuvants which afforded greater protection to the bacilli, under condi-
tions of thermal stress, than did water alone, were considered worthy of
further study. Of all adjuvants tested, only three (sodium glutamate, sodium
aspartate, ascorbic acid*) were capable of maintaining the viability of
vaccine suspensions after prolonged storage at incubator temperatures.
The ability of a combination of adjuvants to protect bacilli during pro-
longed periods of storage and against thermal stress. An examination of the
experimental results indicated that the most favorable adjuvant for pro-
* Titrations carried out after drying in the presence of ascorbic acid show a marked
inhibition of growth at low dilutions. However, when drying is carried out at a dilu-
tion of ascorbic acid that is not inhibitory, the protective effect is no longer obtained.
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longed storage of vaccine suspensions in the cold was glucose, and that the
adjuvant offering the greatest protection against thermal stress was sodium
glutamate. It was decided, therefore, to determine whether or not a com-
bination of the two adjuvants could be used to prepare a vaccine suspension
that would be stable under both of these conditions. BCG strain 862 was
lyophilized in a mixture of optimal concentrations of glucose and sodium
glutamate. Titrations were carried out immediately after lyophilization and
after storage periods of three and ten months. The results are given in
Table 6.
It may be seen that the preservation of the vaccine in the cold, by the use
of combined adjuvants, was poorer than when glucose or sodium glutamate
TABLE 6
THE ABILITY OF A COMBINATION OF ADJUVANTS TO PROTECT BACILLI DURING
PROLONGED PERIODS OF STORAGE AND AGAINST THERMAL STRESS (THE
FIGURES REPRESENT THE NEGATIVE LoGo10 TITER OF GROWTH)
Length of storage
Unlyophil- Immediately 3mnth 10months
ized after 3m__onths 10 months
Nature of adjuvant control lyophilization 4° C. 380 C. 40 C. 38° C.
Glucose and
sodium glutamate 7 6 3 2 2 1
Glucose 6 5 5 1 5 1
Sodium glutamate 6 5 5 4 5 4
was used alone, and that preservation under conditions of thermal stress
was poorer than when sodium glutamate was used alone.
The ability of BCG repeatedly subcultured upon Sauton's meditum to
withstand lyophilization. It has been shown previously"' that serial sub-
culture of BCG on Sauton's medium causes a loss in vitality of the culture,
although introduction of a single passage on potato is sufficient to restore
the vitality of the strain. Loss of vitality is manifested by delayed initial
growth, production of a hydrophilic bacillary mat, decrease in the size of the
bacilli, and diminution in the allergizing powers of the culture. It was of
interest to determine if the decreased vitality of the strain would lead to a
decrease in the ability to withstand the stresses of lyophilization.
BCG strain B59 was chosen for the experiment. An initial transfer from
a glycerinated water potato culture was made to Sauton's medium. Every
tenth day thereafter, for a period of 100 days, a serial subplant was made
from the Sauton culture to a new flask of Sauton's medium. Titrations were
carried out upon each culture to determine the highest dilution to which
growth would occur, and, at the same time, the cultures were lyophilized in
the presence of 20 per cent glucose (final concentration 10 per cent).
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Ampoules were opened for titration immediately after lyophilization. A
comparison was made of the highest dilutions at which the unlyophilized
and lyophilized bacilli grew.
After the tenth serial passage upon Sauton's medium, the culture was
regrown on glycerinated water potato medium. A portion of the veil from
the new culture was transferred to Sauton's medium, and the new first
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FIG. 6. The effect of repeated subculture in Sauton's medium upon the ability of BCG
to withstand lyophilization.
generation was designated Ia. A comparison was made of the highest
dilutions at which the unlyophilized and lyophilized Ia cultures grew.
The results of the experiment are presented in Figure 5. It is evident that
with repeated subculture there was a marked decrease in the viability of the
culture. Coincident with this loss there was a disproportionate decrease in
the ability of the culture to withstand lyophilization. Although the initial
loss after lyophilization in the presence of glucose may be expected to
encompass one, or at the most two, dilution tubes, it may be noted that after
the fourth generation losses exceeded expectation, and that after the eighth
passage, there was no recovery of viable elements from the lyophilized
material.
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It is of further interest to note that a single passage back to potato was
sufficient to restore the ability of the strain to withstand lyophilization, since
the loss suffered by culture Ia following lyophilization amounted to only a
single dilution tube.
DISCUSSION
The ultimate object of this investigation was to secure a stable allergenic
preparation of BCG. Although progress was made in the direction of sta-
bility, it has not been possible, up to this time, to assay the allergenic
properties of the vaccine suspensions. In a discussion of the results it seems
pertinent to indicate the difficulties inherent in this type of work, and to
point out the particular shortcomings that appear here.
Because the allergenicity of BCG vaccine has been shown to be a function
of the degree of viability of the bacterial suspension, attention has been
devoted primarily toward the development of a method for obtaining
lyophilized cultures with the highest possible number of viable cells. It must
be admitted, however, that the assumption cannot be made that the viability
of the vaccine is the only factor involved in the degree of allergenic potency.
Lyophilized vaccine suspensions produced in Japan show relatively high
levels of viability, but less than 50 per cent of such preparations cause
tuberculin conversion. In addition, there appears to be a qualitative differ-
ence in the nature of a positive response to tuberculin, in that the reaction
produced shows a marked increase in inflammation, but a decreased amount
of induration.!
The method of assay used in this investigation was a determination of the
highest dilution at which vaccine preparations gave growth in Youman's
medium, both before and after lyophilization. The same method was utilized
in all assays so that the results are comparable, and are an index of the
effect of different treatments on the relative numbers of viable cells. Al-
though the method gave no indication of the absolute number of viable cells
in the vaccine suspensions it was deemed satisfactory for a comparative
evaluation of the effect of different procedures on viability.
The principal source of error in the assay would arise from those
procedures which tended to aggregate cells at any time during vaccine
preparation, lyophilization, or storage, or which tended to prevent dis-
persion of the vaccine on later dilution. Such aggregation would be reflected
as a diminished population in subsequent titrations of growth and, in the
absence of corrections to account for the clumping of the vaccine, could only
be interpreted as an indication of a low index of efficiency for the adjuvant
concerned.
It must also be realized that any lyophilized vaccine contains cells in three
states of viability: living cells, dead cells, and an intermediate group that
may live or die, depending upon the conditions under which the suspension
is reconstituted. These represent potentially viable cells. Throughout these
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experiments, vaccine suspensions were reconstituted in 0.9 per cent saline.
It is possible that the use of saline did not permit full realization of the
potential population, and that by the use of other diluents growth would
have been secured at higher dilutions. Quite obviously, the determination
of the highest titer of growth is a function of the adequacy of the technical
methods employed for the demonstration of viability.
Errors in evaluating particular procedures or adjuvants might also have
arisen because of lack of knowledge of special conditions affecting perform-
ance. Thus, because of the large number of adjuvants tested, it was not
feasible to determine for each compound the optimal concentration to be
used in lyophilization. Examination of the results summarized in Figure 5
reveals a narrow range of protective concentrations of sodium glutamate.
It is possible that potentially valuable adjuvants have been neglected in this
study because screening tests carried out at a single concentration showed
them to disadvantage.
It has also been difficult to assess the importance of aggregation or
dispersion of the bacterial suspension. Differences in the ability to withstand
the stresses imposed by lyophilization have been correlated with rather
gross changes in the percentage of freely dispersed bacilli. If it is granted
that the aliquot removed from the vaccine suspension for the determination
of the percentage of freely dispersed bacilli was, in fact, representative of
the vaccine suspension, then it would appear that it is easier to stabilize the
single bacterial cell than the clump of bacterial cells. This experimental
finding may have its basis in the difficulty with which an adjuvant reaches
the interior of a bacterial clump. Equally plausible is the contention that
dispersion is effective because it permits more rapid dehydration of the
vaccine suspension and thus prevents the formation of ice crystals within the
cell. Nevertheless, the possibility remains that a clumped bacterial suspen-
sion might act as a depot after inoculation and thus give rise to a heightened
and sustained allergenic stimulus.
Finally, it has not been possible to relate definitely the chemical structure
of the drying adjuvant to its protective capacities. Of seven adjuvants that
afforded protection to the bacilli, three were hexoses, one a hexose deriva-
tive, one a disaccharide, and two, salts of organic acids. Examination of
the experimental data will indicate, however, that, in many cases, chemical
analogues varied rather widely in the degree of protection afforded to the
bacilli. Thus, the indexes of efficiency for the sodium salts of glutamic acid
and glutaric acid were 16 and 34 respectively.
Despite these many objections, however, it seems likely that the following
points have been established.
There was no significant variation in the ability of the different strains
of BCG, or of the vole bacillus, to withstand lyophilization. The success of
freeze-drying was dependent upon the suspending vehicle, rather than upon
inherent differences in the strains.
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Loss in viability of the vaccine suspensions occurs at three times: first,
during the period of vaccine preparation, prior to lyophilization. This initial
loss could be eliminated or minimized by refrigeration of the vaccine or by
the addition of serum albumin. It might be well to note at this point that
refrigeration is, of course, preferable to the addition of serum albumin,
because of the potential danger of inducing serum sickness. Further loss
during the period of lyophilization could be combatted by drying in the
presence of each of a small number of adjuvant solutions. Of 62 adjuvants
investigated only six offered protection to the bacilli during freeze-drying.
Four of these were carbohydrates (galactose, glucose, sucrose, lactose) and
two were salts of organic acids (sodium glutamate, sodium aspartate). The
carbohydrates protected the bacilli during prolonged periods of storage in
the cold, but were inefficient under conditions of thermal stress. Salts of
organic acids were less efficient than carbohydrates, but did confer some
protection against thermal stress.
Although glucose was the most suitable adjuvant for combatting the loss
of viable elements during the period of lyophilization, the compound pre-
sented technical difficulty due to its tendency to "bubble" during the freeze-
drying process. From the standpoint of practicality, lactose, which is rela-
tively less efficient than glucose, might be preferred inasmuch as it does not
"bubble" during lyophilization and has a faster rate of solubility on
reconstitution of the vaccine suspension.
The degree of protection afforded by glucose was independent of concen-
tration over a wide range; sodium glutamate was protective only over a
limited range of concentrations.
Although carbohydrates were desirable as adjuvants for prolonged
preservation of vaccines, these compounds offered little or no protection
when the ampoules were exposed to thermal stress. Only three compounds
were demonstrated to protect bacilli stored at incubator temperature. These
were sodium glutamate, sodium aspartate, and ascorbic acid. The last, how-
ever, because of its aberrant behavior, as indicated earlier in this paper, can-
not be recommended for use. The other two compounds, sodium glutamate
and sodium aspartate, offered marked protection against thermal stress, but
were not as efficient as carbohydrates when storage could be effected at
refrigerator temperature.
When carbohydrates and salts of organic acids were mixed, the resultant
adjuvant solution did not suffice to stabilize the vaccine against both pro-
longed periods of storage in the cold, and storage under conditions of
thermal stress. Indeed, the inherent value of each of the individual com-
ponents was lessened, with consequent degradation of the integrity of the
lyophilized product.
Lyophilization was best accomplished at a neutral pH. Loss in viability
of vaccine suspensions dried at hydrogen ion concentrations on either side
of neutrality became disproportionately large when freeze-dried prepara-
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tions were stored at incubator temperature. It is felt that the importance of
hydrogen ion concentration has been too little appreciated in the past, a fact
attributable both to the length of time for its effect to be noticed in culture,
and also because the potentially adverse conditions of thermal stress have
been assiduously avoided in storage whenever possible.
The efficiency of lyophilization was related to the initial dispersion of the
vaccine suspension. There was a disproportionate decrease in the ability
of poorly dispersed vaccines, in adjuvant solutions, to withstand lyophiliza-
tion. The use of "Tween 80" in the suspending menstruum to encourage
dispersed growth should make it possible to eliminate the lethal effects of
prolonged grinding. It is to be hoped that the preliminary reports on the use
of "Tween 80" in the suspending vehicle15 will soon be followed by a detailed
analysis.
"Lyophile" preparations of old cultures (20 to 25 days) showed a
decreased ability to withstand storage at both refrigerator and incubator
temperatures. The loss in viability was most marked when the ampoules
were stored at 370 C. However, with 25-day-old cultures, no viable cells
were recovered from lyophilized material kept at either refrigerator or
incubator temperatures. It would seem quite evident that if a high degree of
viability is to be expected in a lyophilized preparation, the culture from
which the vaccine is prepared must itself contain a high percentage of viable
cells. Traditional Calmette technique calls for the use of a 21- to 30-day-old
BCG culture, but such a culture has long passed its period of exponential
growth and is composed predominantly of dead cells. The use of such a
culture is open to question.
Repeated subculture of BCG on Sauton's medium led to a marked
decrease in the vitality of the culture, and a disproportionate decrease in
the ability of the culture to withstand lyophilization. Vitality could be
restored by a single passage back to glycerinated water potato medium. It
would appear wise to limit the number of consecutive transfers of the BCG
culture on Sauton's medium, and any delay in the appearance of initial
growth should be taken as indication of the necessity of repassaging the
culture back to a potato medium.
It has not been possible in this study to confirm the reports of relatively
slight loss of viable elements during lyophilization."a" Claims of high
recovery rates after lyophilization must be regarded with some reserve and
must be evaluated in accordance with the techniques employed for the
enumeration of the viable elements in a vaccine suspension. The greatest
efficiency of drying obtained in this investigation has been 10 per cent.
Because the experimental results indicate clearly the difficulty of
stabilizing BCG in the absence of adjuvants, it is of interest to consider
what role the adjuvant actually may play in stabilization. The theories
generally advanced fall into two categories, the physical and the physiologi-
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cal. The following may be cited as examples of physical explanations of
adjuvant action:
1. The adjuvant solution prevents microtrauma to the bacterial cell by
inhibiting the formation, at low temperatures, of ice crystals within the cell.
2. The adjuvant adheres to the cell wall, and, in this manner, renders the
cell impermeable.
3. The adjuvant solutions shrink the cell so that it does not undergo
plasmoptysis on reconstitution of the dried suspension.
In contrast, the following physiological explanations have been offered
for consideration.
1. The adjuvant solution penetrates the cell and by some unknown
process, possibly competitive inhibition, manages to suppress the metabolic
activities of the cell.
2. The adjuvant exerts a protective effect or "sparing action" upon an
essential cell metabolite.
It does not necessarily follow that the explanation of adjuvant action must
be either entirely physical or physiological, and, undoubtedly, both factors
are operative. However, in the domain of physical explanations, it is diffi-
cult to see how the soluble substances which have been demonstrated in this
study to exert a protective action, could constitute a somatic barrier to
render a bacterial cell impermeable.
Because of the possibility that adjuvants exert their protective action at
a metabolic rather than at a structural level it would have been extremely
interesting had all of the substances shown to be effective in stabilizing the
vaccine suspensions been physiologically active. This was, however, not the
case, and one of the best adjuvants, lactose, apparently plays no part in the
metabolism of mycobacteria. Similarly, sucrose is not utilized by the organ-
ism, and sodium glutamate, the adjuvant that confers the greatest protection
against thermal stress, under experimental conditions causes such small
increments in the Qo2 of washed cell suspensions that its importance to the
metabolic economy of the organism is questionable.
This investigation has, therefore, failed to clarify the nature of adjuvant
action.
SUMMARY
An investigation has been undertaken to determine in what manner
cellular mortality of BCG might be kept to a minimum during lyophiliza-
tion. No significant variation in the ability of nine strains of BCG and one
strain of the vole bacillus to withstand lyophilization has been demonstrated.
The success of freeze-drying has been shown to be dependent upon the age
of the culture used for lyophilization, its degree of dispersion, and the initial
neutrality of the suspending vehicle. The effect of prolonged standing, at
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room and refrigerator temperatures, upon the viability of vaccine suspen-
sions, and of repeated subculture of the BCG strain have been assessed.
Sixty-two adjuvants, embracing the general classes of carbohydrates,
organic acids, amino acids and their salts, proteins and digests, gums, and
miscellaneous reagents have been investigated with respect to their ability
to protect vaccine suspensions during lyophilization and storage and against
thermal stress. Of six adjuvants demonstrated to protect bacilli during
freeze-drying, four were carbohydrates (galactose, glucose, sucrose, lac-
tose) and two were salts of organic acids (sodium glutamate, sodium
aspartate). The protective capacities of the carbohydrates were superior to
those of the salts of organic acids when storage could be effected at refriger-
ator temperature, but were inferior when storage was effected at higher
temperatures.
The optimal concentrations of selected adjuvants to be used for lyophiliza-
tion have been determined. The inability of a combination of adjuvants
(glucose and sodium glutamate) to protect bacilli during prolonged periods
of storage at refrigerator and incubator temperatures has been demonstrated.
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